Patents by Inventor Daoyun ZHANG

Daoyun ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncolytic virus vector and application thereof
    Patent number: 11987802
    Abstract: The embodiments of the present disclosure may provide an oncolytic virus vector and an application thereof. The oncolytic virus vector may comprise a recombinant nucleic acid. The recombinant nucleic acid may include: (i) a first nucleic acid fragment encoding a soluble PD-1 molecule; (ii) a second nucleic acid fragment encoding a CD86 molecule; and (iii) a third nucleic acid fragment encoding an antibody to a CD3 molecule.
    Type: Grant
    Filed: July 11, 2023
    Date of Patent: May 21, 2024
    Assignee: SHANGHAI YUNYING BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Ziying Gong, Daoyun Zhang, Yonghua Sun, Yi Wang, Nan Shi, Jun Zhu, Miao Ding
  • ONCOLYTIC VIRUS VECTOR AND APPLICATION THEREOF
    Publication number: 20240002884
    Abstract: The embodiments of the present disclosure may provide an oncolytic virus vector and an application thereof. The oncolytic virus vector may comprise a recombinant nucleic acid. The recombinant nucleic acid may include: (i) a first nucleic acid fragment encoding a soluble PD-1 molecule; (ii) a second nucleic acid fragment encoding a CD86 molecule; and (iii) a third nucleic acid fragment encoding an antibody to a CD3 molecule.
    Type: Application
    Filed: July 11, 2023
    Publication date: January 4, 2024
    Applicant: SHANGHAI YUNYING BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Ziying GONG, Daoyun ZHANG, Yonghua SUN, Yi WANG, Nan SHI, Jun ZHU, Miao DING